Colfax Corporation (NYSE:CFX) is looking for strategic bolt-ons acquisitions. Matthew Trerotola, President, Chief Executive Officer & Director said, "we've talked openly about seeing a clear path to $2 billion plus that is really about organic growth and strategic bolt-ons. We'll be somewhere in the $1.6 billion -- $1.5 billion and $1.6 billion range pro forma going in stepping into next year.

And so the path from there to $2 billion plus is a pretty quick one that we don't -- we can do with smaller bolt-on acquisitions within orthopedics that strengthen and enhance our businesses".